Bridging the gap: glucose transporters, Alzheimer's, and future therapeutic prospects

M Albaik, D Sheikh Saleh, D Kauther… - Frontiers in Cell and …, 2024 - frontiersin.org
Glucose is the major source of chemical energy for cell functions in living organisms. The
aim of this mini-review is to provide a clearer and simpler picture of the fundamentals of …

SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis

Y Zhang, H Qin, J Bian, Z Ma, H Yi - Frontiers in Pharmacology, 2022 - frontiersin.org
Facilitative glucose transporters (GLUTs), which are encoded by solute carrier 2A (SLC2A)
genes, are responsible for mediating glucose absorption. In order to meet their higher …

Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria

H Fang, D Lin, X Li, L Wang, T Yang - Frontiers in Pharmacology, 2023 - frontiersin.org
Introduction: In the Doxorubicin (DOX)-induced nephropathy model, proteinuria is a
manifestation of progressive kidney injury. The pathophysiology of renal illness is heavily …

LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression

J Guan, ZY Zhang, JH Sun, XP Wang, ZQ Zhou… - Clinical & Experimental …, 2023 - Springer
Lipopolysaccharide-induced tumor necrosis factor alpha factor (LITAF) is a transcription
factor that activates the transcription of TNF-α and regulates the inflammatory response …

Solute carrier family 2 members (SLC2A) as potential targets for the treatment of head and neck squamous cell carcinoma patients

AK Tiwari, D Jain, S Nizamuddin, RS Srivastava… - Human Gene, 2025 - Elsevier
Objective Solute carrier family 2 (SLC2A) members have drawn interest in cancer research
due to their crucial function in glucose metabolism. To understand their role in Head and …

[HTML][HTML] Understanding the Spectrum of Mild Clinical Outcomes and Novel Findings in Arterial Tortuosity Syndrome Among Qatari Patients: Implications of SLC2A10 …

MRK Rahmath, H Ibrahim, M Faiyaz-Ul-Haque… - Biomedicines, 2025 - mdpi.com
Background/Objectives: Arterial Tortuosity Syndrome (ATS) is a rare, autosomal recessive
connective tissue disorder characterized by arterial twists, abnormal bulges, constriction …

Giant aortic aneurysm repair in a child due to arterial tortuosity syndrome

D Budrys, V Tarutis, K Jonas - Cardiology in the Young, 2024 - cambridge.org
Arterial tortuosity syndrome is an extremely rare hereditary connective tissue disorder. We
present a case of an incidentally diagnosed aneurysm of the aortic root and the ascending …